Warner Carr

Statistics

Publications

Citations

250

H-Index

Active since

2009

Affiliations

California Allergy and Asthma Medical Group(Current)

AstraZeneca (United States)

Allergy, Asthma and Clinical Research Center

Rutgers, The State University of New Jersey

Capital Allergy and Respiratory Disease Center

Warner Carr is an author at California Allergy and Asthma Medical Group specializing in asthma management, asthma pharmacotherapy, and severe asthma treatment.

Publications per year

2009–2024

Publications

Remibrutinib demonstrates favorable safety profile and sustained efficacy in chronic spontaneous urticaria over 52 weeks

Vipul Jain, Ana M. Giménez‐Arnau, Koremasa Hayama et al. · Journal of Allergy and Clinical Immunology · 2023 · 68 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Severe asthma exacerbations in the United States:

Jennifer Trevor, Njira Lugogo, Warner Carr et al. · Annals of Allergy Asthma & Immunology · 2021 · 40 citations

Medicine, Internal Medicine, Disease Surveillance +15

Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial

Sabine Altrichter, Ana M. Giménez‐Arnau, Jonathan A. Bernstein et al. · British Journal of Dermatology · 2024 · 37 citations · Full text

Life Sciences, Dermatology, Immunology +17

Real-world severe asthma biologic administration and adherence differs by biologic

Dennis K. Ledford, Weily Soong, Warner Carr et al. · Annals of Allergy Asthma & Immunology · 2023 · 29 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +17

Biologic use and outcomes among adults with severe asthma treated by US subspecialists

Reynold A. Panettieri, Dennis K. Ledford, Bradley E. Chipps et al. · Annals of Allergy Asthma & Immunology · 2022 · 25 citations

Medicine, Internal Medicine, Pharmacotherapy +16

1–5 of 9